United States · Business magazines · Forbes
Ebola Vaccine Trials Begin In DRC As Death Toll Nears 4,700
Late-stage trials for a vaccine targeting the deadly Bundibugyo Ebola strain have launched in the DCR as the country continues to struggle under its most deadly Ebola outbreak…
Read the full article on Forbes Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.forbes.com)





